FIELD: medicine.
SUBSTANCE: composition includes an aqueous solution of fullerene C60, vaseline, sucrose palmitate, as well as parabens - nipasol and nipagin in a weight ratio of 4:3.78:2.2:0.001:0.001. The final content of fullerene in the composition is 0.005 to 0.012 wt %.
EFFECT: invention allows reduction of inflammatory leukocyte infiltration of the epidermis.
1 cl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF FULLERENE C60 AQUEOUS SOLUTION AS THERAPEUTIC AGENT AT ATOPIC DERMATITIS DISEASE | 2016 |
|
RU2641091C1 |
METHOD FOR PRODUCTION OF FULLERENE WATER-SALT DISPERSIONS | 2015 |
|
RU2630561C2 |
MEANS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2022 |
|
RU2794841C1 |
COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
METHOD OF OBTAINING A HIGHLY CONCENTRATED AQUEOUS SOLUTION FULLERENE | 2018 |
|
RU2679257C1 |
METHOD FOR PRODUCING AQUEOUS NANODISPERSIONS OF FULLEREN | 2013 |
|
RU2548971C2 |
METHOD FOR ALLERGIC BRONCHIAL ASTHMA TREATMENT, BASED ON CYTOKINES IL-4 AND IL-13 GENES EXPRESSION INHIBITION USING SIRNA MOLECULES | 2016 |
|
RU2615463C1 |
ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
PHARMACEUTICAL COMPOSITION POSSESSING THERAPEUTIC ACTION ON VARIOUS SKIN PATHOLOGIES | 2014 |
|
RU2549475C1 |
EXTRACT FROM ABOVEGROUND PARTS OF OAT GROWN BEFORE EAR FORMATION | 2009 |
|
RU2517346C2 |
Authors
Dates
2018-01-15—Published
2016-12-15—Filed